178 related articles for article (PubMed ID: 30062986)
61. Ivermectin and filariasis.
Richard-Lenoble D; Chandenier J; Gaxotte P
Fundam Clin Pharmacol; 2003 Apr; 17(2):199-203. PubMed ID: 12667230
[TBL] [Abstract][Full Text] [Related]
62. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
Richards FO; Eigege A; Miri ES; Kal A; Umaru J; Pam D; Rakers LJ; Sambo Y; Danboyi J; Ibrahim B; Adelamo SE; Ogah G; Goshit D; Oyenekan OK; Mathieu E; Withers PC; Saka YA; Jiya J; Hopkins DR
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1346. PubMed ID: 22022627
[TBL] [Abstract][Full Text] [Related]
63. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.
Hoerauf A; Mand S; Fischer K; Kruppa T; Marfo-Debrekyei Y; Debrah AY; Pfarr KM; Adjei O; Büttner DW
Med Microbiol Immunol; 2003 Nov; 192(4):211-6. PubMed ID: 12684759
[TBL] [Abstract][Full Text] [Related]
64. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
Macfarlane CL; Budhathoki SS; Johnson S; Richardson M; Garner P
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003753. PubMed ID: 30620051
[TBL] [Abstract][Full Text] [Related]
65. Integrated Prevalence Assessment of Wuchereria bancrofti and Onchocerca volvulus in Three Co-Endemic Districts of Gambella Region, Ethiopia.
Hassen M; Mohammed A; Endeshaw T; Seid T; Samuel F; Asmare T; Birhanu H; Bekele F; Yayeh A; Seife F; Tamiru M; Meribo K; Tadesse Z; Griswold E; Katabarwa M; Richards F; Noland GS
Am J Trop Med Hyg; 2023 Oct; 109(4):844-849. PubMed ID: 37696513
[TBL] [Abstract][Full Text] [Related]
66. Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
Kamara W; Zoerhoff KL; Toubali EH; Hodges MH; Bisanzio D; Chowdhury D; Sonnie M; Magbity E; Samai M; Conteh A; Macarthy F; Baker M; Koroma JB
PLoS One; 2019; 14(12):e0224422. PubMed ID: 31856176
[TBL] [Abstract][Full Text] [Related]
67. Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
Efon-Ekangouo A; Nana-Djeunga HC; Nzune-Toche N; Dongmo-Yemele R; Bopda J; Ongbassomben V; Sumo L; Geiger A; Nutman TB; Kamgno J
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011250. PubMed ID: 37058547
[TBL] [Abstract][Full Text] [Related]
68. Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé Foci, Mali.
Dolo H; Coulibaly YI; Sow M; Dembélé M; Doumbia SS; Coulibaly SY; Sangare MB; Dicko I; Diallo AA; Soumaoro L; Coulibaly ME; Diarra D; Colebunders R; Nutman TB; Walker M; Basáñez MG
Clin Infect Dis; 2021 May; 72(9):1585-1593. PubMed ID: 32206773
[TBL] [Abstract][Full Text] [Related]
69. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
[TBL] [Abstract][Full Text] [Related]
70. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
[TBL] [Abstract][Full Text] [Related]
71. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
[TBL] [Abstract][Full Text] [Related]
72. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
[TBL] [Abstract][Full Text] [Related]
73. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
Plaisier AP; Stolk WA; van Oortmarssen GJ; Habbema JD
Parasitol Today; 2000 Jul; 16(7):298-302. PubMed ID: 10858649
[TBL] [Abstract][Full Text] [Related]
74. Lymphedema in three previously Wuchereria bancrofti-endemic health districts in Mali after cessation of mass drug administration.
Dolo H; Coulibaly YI; Konipo FN; Coulibaly SY; Doumbia SS; Sangare MB; Soumaoro L; Coulibaly ME; Diallo AA; Diarra Y; Sangare M; Doumbia S; Colebunders R; Nutman TB
BMC Infect Dis; 2020 Jan; 20(1):48. PubMed ID: 31941448
[TBL] [Abstract][Full Text] [Related]
75. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
Otabil KB; Gyasi SF; Awuah E; Obeng-Ofori D; Atta-Nyarko RJ; Andoh D; Conduah B; Agbenyikey L; Aseidu P; Ankrah CB; Nuhu AR; Schallig HDFH
BMC Infect Dis; 2019 May; 19(1):431. PubMed ID: 31101085
[TBL] [Abstract][Full Text] [Related]
76. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
[TBL] [Abstract][Full Text] [Related]
77. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
[TBL] [Abstract][Full Text] [Related]
78. Mass drug treatment for lymphatic filariasis and onchocerciasis.
Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
[No Abstract] [Full Text] [Related]
79. Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania.
Lupenza E; Gasarasi DB; Minzi OM
Infect Dis Poverty; 2021 Mar; 10(1):20. PubMed ID: 33648600
[TBL] [Abstract][Full Text] [Related]
80. Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.
Marks M; Romani L; Sokana O; Neko L; Harrington R; Nasi T; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
Clin Infect Dis; 2020 Apr; 70(8):1591-1595. PubMed ID: 31131410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
